Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -0.026M
September 30, 2023 -0.013M
June 30, 2023 -0.033M
March 31, 2023 -0.12M
December 31, 2022 -0.036M
September 30, 2022 -0.126M
June 30, 2022 9.85M
March 31, 2022 -0.029M
December 31, 2021 9.801M
September 30, 2021 0.042M
June 30, 2021 12.40M
March 31, 2021 2.553M
December 31, 2020 6.372M
September 30, 2020 -33.26M
June 30, 2020 -9.303M
March 31, 2020 -0.067M
December 31, 2019 -0.026M
September 30, 2019 -0.291M
June 30, 2019 -0.25M
March 31, 2019 -0.194M
Date Value
December 31, 2018 0.357M
September 30, 2018 -0.351M
June 30, 2018 -0.543M
March 31, 2018 -0.056M
December 31, 2017 0.125M
September 30, 2017 -0.133M
June 30, 2017 -0.874M
March 31, 2017 -1.594M
December 31, 2016 -0.893M
September 30, 2016 -1.421M
June 30, 2016 -1.015M
March 31, 2016 -2.158M
December 31, 2015 -1.874M
September 30, 2015 -1.916M
June 30, 2015 -2.644M
March 31, 2015 -1.46M
December 31, 2014 -1.045M
September 30, 2014 -0.531M
June 30, 2014 -0.245M
March 31, 2014 -0.263M
December 31, 2013 -0.063M
September 30, 2013 -0.03M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
ABVC BioPharma, Inc. -0.0235M
Anika Therapeutics, Inc. -1.756M
Perspective Therapeutics, Inc. 23.73M
MiMedx Group, Inc. -0.193M
Abbott Laboratories -385.00M